Blocking agent for inhibiting infection of High Pathogenic Porcine Reproductive and Respiratory Syndrome Virus
A syndrome virus and highly pathogenic technology, applied in the field of biology, can solve the problems of low cross-immunity protection of common strains, unsatisfactory vaccine immune effect, difficulties in HP-PRRSV prevention and treatment, etc., to expand the scope of research, Reduce the effect of inhibitory activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] Embodiment 1: Participate in the identification of PRRSV infection 14-3-3 subtype
[0052] In the early stage, we connected the PRRSV non-structural protein nsp2 gene to the eukaryotic expression vector, expressed it in 293T cells, collected the cellular proteins that might interact with nsp2 through GFP-Trap agarose beads, and found that the cellular protein 14 was verified by mass spectrometry and Western blot -3-3 interacts with nsp2 (Xiao et al, J Proteome Res. 2016, 15(5):1388-1401). In order to further study which subtype of 14-3-3 is involved in PRRSV infection, two subtypes of 14-3-3β and ε were selected according to the mass spectrometry results, and siRNAs targeting these two subtypes were designed. After reducing their expression, analysis Effects on HP-PRRSV infection.
[0053] According to the 14-3-3β and ε gene sequences published by NCBI (GenBank accession numbers: XM008009806.1, XM_017028039.2), primers were designed to amplify the 14-3-3β and 14-3-3ε g...
Embodiment 2
[0059] Example 2: Construction of 14-3-3 protein overexpression cell line and its effect on PRRSV infection
[0060] (1) 14-3-3 lentivirus construction
[0061] According to the 14-3-3 gene sequence registered in GenBank, design primers for amplifying different subtypes of 14-3-3, as follows:
[0062] 14-3-3β-leti: Forward primer 5'-CGGGATCCATGACAATGGATAAAAGTGAG-3'; Reverse primer 5'-CCCGAATTCTTAGTTCTCTCCCCTCCCCAG-3'.
[0063] 14-3-3ε-leti: forward primer 5'-CGGGATCCATGGATGATCGAGAGGATCTG-3'; reverse primer 5'-CCCGAATTCTCACTGATTTTCGTCTTCCAC-3'.
[0064] Respectively with BamH I, EcoR I restriction enzyme sites. Using the RNA from Marc145 cells as a template, the target fragment was cloned, and the target fragment digested by restriction enzymes was ligated with the lentiviral empty vector pwpxld overnight at 16°C. Transform into T1 competent, pick a single colony for PCR, enzyme digestion verification and sequence determination verification. A large number of extracted and ...
Embodiment 3
[0069] Example 3: Knockdown of 14-3-3ε on PAM and its effect on HP-PRRSV infection
[0070] In order to further verify the results, primary porcine lung macrophages (PAM) were used for verification. The 50-day-old SPF piglets were bled, their lungs were aseptically removed after the trachea was ligated, and the outer surface was washed with autoclaved PBS (1640 medium with 1 / 25 volume of PBS and 5× double antibody), and the pH7 .2 Infuse 30.0ml-50ml of PBS into the lungs from the trachea, gently pat the lung surface, recover the lavage fluid after 1-2 minutes, and repeat this process until the lavage fluid is clear. Gently blow the recovered bronchoalveolar lavage fluid with a straw to break up the cell clumps, filter through a single-layer sterile 100-mesh stainless steel sieve, collect all the lavage fluid, centrifuge at 1500r / min for 5-10min, and collect the precipitate. Wash twice with PBS containing 5× double antibody, each time gently mix and centrifuge. Then add an ap...
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com